Peripheral Vascular Stents Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Peripheral Vascular Stents Pipeline Products Market Report Overview

A peripheral vascular stent is an expandable perforated tube that is inserted into a peripheral vessel to prevent blood flow constriction. The Peripheral Vascular Stents pipeline market research report provides comprehensive information about the Peripheral Vascular Stents pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Peripheral Vascular Stents Pipeline Products Market Segments

The key segments in the Peripheral Vascular Stents Pipeline Products market are Bioabsorbable Stents (BAS), Drug Eluting Stents (DES), Iliac Artery Stents, Tracheobronchial Stent, and Bare Metal Stents (BMS). As of February 2023, Bioabsorbable Stents (BAS) dominated the market.

Peripheral Vascular Stents Pipeline Products Market Analysis by Segments, 2023 (%)

Peripheral Vascular Stents Pipeline Products Market Analysis by Segments, 2023 (%)

For more segments insights into the Peripheral Vascular Stents pipeline products market, download a free report sample

Peripheral Vascular Stents Pipeline Products Market Segmentation by Territories

The key territories with products in the pipeline are the US, China, Europe, Japan, India, New Zealand, the UK, Mauritius, and Canada. As of February 2023, the US has the highest number of products in the pipeline out of them all.

Peripheral Vascular Stents Pipeline Products Market Analysis, by Territories, 2023 (%)

Peripheral Vascular Stents Pipeline Products Market Analysis, by Territories, 2023 (%)

For more territory insights into the Peripheral Vascular Stents pipeline products market, download a free report sample

Peripheral Vascular Stents Pipeline Products Market Segmentation by Regulatory Paths

The key regulatory paths followed by the Peripheral Vascular Stents pipeline products market are PMA, NMPA, CE, Shonin, ICAC, 510(k), TGA, UKCA, and MDL. Most of the products follow the PMA pathway to enter the market.

Peripheral Vascular Stents Pipeline Products Market Analysis, by Regulatory Paths, 2023 (%)

Peripheral Vascular Stents Pipeline Products Market Analysis, by Regulatory Paths, 2023 (%)

For more Peripheral Vascular Stents pipeline products regulatory path insights, download a free report sample

Peripheral Vascular Stents Pipeline Products Market - Competitive Landscape

LLC, Abbott Vascular Inc, Abbott Vascular Inc, Acotec Scientific Holdings Ltd, Acotec Scientific Holdings Ltd, amg International GmbH, AndraTec GmbH, Arterius Ltd, Biotyx Medical (Shenzhen) Co Ltd, and Boston Scientific Corp.

Abbott Vascular Inc: headquartered in California, USA, Abbott Vascular develops, manufactures, and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. Abbott Vascular’s peripheral intervention products comprise peripheral guide wires, dilatation catheters, guiding catheters, and stent-grafts. The company provides minimally invasive treatment for mitral regurgitation and other structural defects of the heart. It also offers education and training services for healthcare professionals.

amg International GmbH: Headquartered in Winsen, Germany, amg International is a medical device company that develops, manufactures, and markets stents, stent implantation systems and balloon catheters, and other auxiliary products. It provides coronary vascular intervention products and peripheral vascular intervention products.

Boston Scientific Corp: Headquartered in Massachusetts, USA, Boston Scientific is involved in the development, manufacturing, and commercialization of devices for a range of interventional medical specialties. Boston Scientific serves hospitals, clinics, outpatient facilities, and medical offices across the world. The company has manufacturing facilities in the US, Ireland, Costa Rica, Brazil, Malaysia, Puerto Rico, and Switzerland. It sells products directly and through a network of distributors and dealers in Europe, the Middle East, Africa, Asia Pacific, and the Americas.

For more information on leading players in the Peripheral Vascular Stents pipeline products market, download a free report sample

Peripheral Vascular Stents Pipeline Products Market Report Overview

Key Segments Bioabsorbable Stents (BAS), Drug Eluting Stents (DES), Iliac Artery Stents, Tracheobronchial Stent, and Bare Metal Stents (BMS)
Key Territories The US, China, Europe, Japan, India, New Zealand, the UK, Mauritius, and Canada
Key Regulatory Paths PMA, NMPA, CE, Shonin, ICAC, 510(k), TGA, UKCA, and MDL
Leading Companies 3D Biotek LLC, Abbott Vascular Inc, Abbott Vascular Inc, Acotec Scientific Holdings Ltd, Acotec Scientific Holdings Ltd, amg International GmbH, AndraTec GmbH, Arterius Ltd, Biotyx Medical (Shenzhen) Co Ltd, and Boston Scientific Corp

Scope

This report provides:

  • Extensive coverage of the peripheral vascular stents under development.
  • Details of major pipeline products which include product description, licensing, collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of peripheral vascular stents and lists all their pipeline projects.
  • The coverage of pipeline products based on various stages of development ranging from early development to the approved/issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Vascular Stents under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

3D Biotek LLC
Abbott Vascular Inc
Acotec Scientific Holdings Ltd
amg International GmbH
AndraTec GmbH
Arterius Ltd
Biotyx Medical (Shenzhen) Co Ltd
Boston Scientific Corp
Cardinal Health Inc
Cook Medical Inc
Cordis Corp
CorInnova, Inc.
Cytograft Tissue Engineering Inc (Inactive)
Efemoral Medical LLC
Efferent Labs Inc
Electroformed Stents Inc
Elixir Medical Corp
Endomimetics LLC
FIT Biotech Oy (Inactive)
HeMo Bioengineering Ltd
ID Nest Medical SAS
InspireMD Inc
Intressa Vascular SA
Kyoto Medical Planning Co Ltd
LeoMed, LLC
Lepu Medical Technology (Beijing) Co Ltd
LimFlow SA
Lyra Therapeutics Inc
Meril Life Sciences Pvt Ltd
Micell Technologies Inc
Micro Medical Solutions Inc
Natec Medical Ltd
Nipro Corp
NSVascular, Inc.
OrbusNeich
PeriTec Biosciences Ltd
QualiMed Innovative Medizinprodukte GmbH
Qvanteq AG
Reflow Medical, Inc.
Shanghai Bio-heart Biological Technology Co Ltd
Shanghai Changde Medical Technology Co Ltd
Shanghai MicroPort Endovascular MedTech Co Ltd
Shenzhen Salubris Pharmaceuticals Co Ltd
Suzhou Yinluo Medical Devices Co Ltd
Synergy Flow Ltd
Tepha Inc
TissueGen Inc
Tractivus SL
University of Michigan
University of Pittsburgh
University of Pittsburgh Medical Center
Vascular Bioresorbable Technologies
Vascular Concepts Ltd
Vesper Medical Inc
Vinnova
VueKlar Cardiovascular Ltd (Inactive)
Wake Forest University Health Sciences
Xenogenics Corporation
Zorion Medical
Zylox-Tonbridge Medical Technology Co Ltd

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 13

2 Introduction 14

2.1 Peripheral Vascular Stents Overview 14

3 Products under Development 15

3.1 Peripheral Vascular Stents – Pipeline Products by Stage of Development 15

3.2 Peripheral Vascular Stents – Pipeline Products by Segment 16

3.3 Peripheral Vascular Stents – Pipeline Products by Territory 17

3.4 Peripheral Vascular Stents – Pipeline Products by Regulatory Path 18

3.5 Peripheral Vascular Stents – Pipeline Products by Estimated Approval Date 19

3.6 Peripheral Vascular Stents – Ongoing Clinical Trials 20

4 Peripheral Vascular Stents – Pipeline Products under Development by Companies 21

4.1 Peripheral Vascular Stents Companies – Pipeline Products by Stage of Development 21

4.2 Peripheral Vascular Stents – Pipeline Products by Stage of Development 24

5 Peripheral Vascular Stents Companies and Product Overview 27

5.1 3D Biotek LLC Company Overview 27

5.1.1 3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview 27

5.2 Abbott Vascular Inc Company Overview 28

5.2.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.3 Acotec Scientific Holdings Ltd Company Overview 32

5.3.1 Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

5.4 amg International GmbH Company Overview 36

5.4.1 amg International GmbH Pipeline Products & Ongoing Clinical Trials Overview 36

5.5 AndraTec GmbH Company Overview 37

5.5.1 AndraTec GmbH Pipeline Products & Ongoing Clinical Trials Overview 37

5.6 Arterius Ltd Company Overview 38

5.6.1 Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

5.7 Biotyx Medical (Shenzhen) Co Ltd Company Overview 39

5.7.1 Biotyx Medical (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

5.8 Boston Scientific Corp Company Overview 42

5.8.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 42

5.9 Cardinal Health Inc Company Overview 48

5.9.1 Cardinal Health Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.10 Cook Medical Inc Company Overview 49

5.10.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 49

5.11 Cordis Corp Company Overview 51

5.11.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 51

5.12 CorInnova, Inc. Company Overview 56

5.12.1 CorInnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56

5.13 Cytograft Tissue Engineering Inc (Inactive) Company Overview 57

5.13.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57

5.14 Efemoral Medical LLC Company Overview 58

5.14.1 Efemoral Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 58

5.15 Efferent Labs Inc Company Overview 59

5.15.1 Efferent Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.16 Electroformed Stents Inc Company Overview 60

5.16.1 Electroformed Stents Inc Pipeline Products & Ongoing Clinical Trials Overview 60

5.17 Elixir Medical Corp Company Overview 63

5.17.1 Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 63

5.18 Endomimetics LLC Company Overview 64

5.18.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 64

5.19 FIT Biotech Oy (Inactive) Company Overview 65

5.19.1 FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 65

5.20 HeMo Bioengineering Ltd Company Overview 67

5.20.1 HeMo Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 67

5.21 ID Nest Medical SAS Company Overview 68

5.21.1 ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview 68

5.22 InspireMD Inc Company Overview 69

5.22.1 InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 69

5.23 Intressa Vascular SA Company Overview 70

5.23.1 Intressa Vascular SA Pipeline Products & Ongoing Clinical Trials Overview 70

5.24 Kyoto Medical Planning Co Ltd Company Overview 71

5.24.1 Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 71

5.25 LeoMed, LLC Company Overview 73

5.25.1 LeoMed, LLC Pipeline Products & Ongoing Clinical Trials Overview 73

5.26 Lepu Medical Technology (Beijing) Co Ltd Company Overview 74

5.26.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 74

5.27 LimFlow SA Company Overview 75

5.27.1 LimFlow SA Pipeline Products & Ongoing Clinical Trials Overview 75

5.28 Lyra Therapeutics Inc Company Overview 79

5.28.1 Lyra Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.29 Meril Life Sciences Pvt Ltd Company Overview 81

5.29.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 81

5.30 Micell Technologies Inc Company Overview 87

5.30.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 87

5.31 Micro Medical Solutions Inc Company Overview 88

5.31.1 Micro Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 88

5.32 Natec Medical Ltd Company Overview 91

5.32.1 Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 91

5.33 Nipro Corp Company Overview 92

5.33.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 92

5.34 NSVascular, Inc. Company Overview 93

5.34.1 NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 93

5.35 OrbusNeich Company Overview 94

5.35.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 94

5.36 PeriTec Biosciences Ltd Company Overview 96

5.36.1 PeriTec Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 96

5.37 QualiMed Innovative Medizinprodukte GmbH Company Overview 98

5.37.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 98

5.38 Qvanteq AG Company Overview 100

5.38.1 Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview 100

5.39 Reflow Medical, Inc. Company Overview 101

5.39.1 Reflow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 101

5.40 Shanghai Bio-heart Biological Technology Co Ltd Company Overview 104

5.40.1 Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 104

5.41 Shanghai Changde Medical Technology Co Ltd Company Overview 105

5.41.1 Shanghai Changde Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 105

5.42 Shanghai MicroPort Endovascular MedTech Co Ltd Company Overview 108

5.42.1 Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 108

5.43 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview 109

5.43.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 109

5.44 Suzhou Yinluo Medical Devices Co Ltd Company Overview 112

5.44.1 Suzhou Yinluo Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 112

5.45 Synergy Flow Ltd Company Overview 113

5.45.1 Synergy Flow Ltd Pipeline Products & Ongoing Clinical Trials Overview 113

5.46 Tepha Inc Company Overview 114

5.46.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 114

5.47 TissueGen Inc Company Overview 115

5.47.1 TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview 115

5.48 Tractivus SL Company Overview 116

5.48.1 Tractivus SL Pipeline Products & Ongoing Clinical Trials Overview 116

5.49 University of Michigan Company Overview 117

5.49.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 117

5.50 University of Pittsburgh Company Overview 118

5.50.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 118

5.51 University of Pittsburgh Medical Center Company Overview 119

5.51.1 University of Pittsburgh Medical Center Pipeline Products & Ongoing Clinical Trials Overview 119

5.52 Vascular Bioresorbable Technologies Company Overview 120

5.52.1 Vascular Bioresorbable Technologies Pipeline Products & Ongoing Clinical Trials Overview 120

5.53 Vascular Concepts Ltd Company Overview 122

5.53.1 Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview 122

5.54 Vesper Medical Inc Company Overview 124

5.54.1 Vesper Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 124

5.55 Vinnova Company Overview 127

5.55.1 Vinnova Pipeline Products & Ongoing Clinical Trials Overview 127

5.56 VueKlar Cardiovascular Ltd (Inactive) Company Overview 128

5.56.1 VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 128

5.57 Wake Forest University Health Sciences Company Overview 130

5.57.1 Wake Forest University Health Sciences Pipeline Products & Ongoing Clinical Trials Overview 130

5.58 Xenogenics Corporation Company Overview 131

5.58.1 Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview 131

5.59 Zorion Medical Company Overview 133

5.59.1 Zorion Medical Pipeline Products & Ongoing Clinical Trials Overview 133

5.60 Zylox-Tonbridge Medical Technology Co Ltd Company Overview 134

5.60.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 134

6 Peripheral Vascular Stents- Recent Developments 140

6.1 Dec 08, 2022: Edwards Lifesciences Announces CEO Succession Plan 140

6.2 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer 140

6.3 Nov 23, 2022: Medtronic Reports Quarterly Earnings 141

6.4 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 141

6.5 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 147

6.6 Nov 11, 2022: Olympus Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023 147

6.7 Nov 11, 2022: Olympus Announces Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023 149

6.8 Nov 10, 2022: Terumo Corp Announces Consolidated Financial Results for the Second Quarter Ended September 30, 2022 149

6.9 Oct 21, 2022: Olympus Announces Leadership Succession Plan 149

6.10 Oct 21, 2022: Olympus Corp Notice Concerning Changes of Representative Executive Officer and Management Team 149

6.11 Oct 20, 2022: Edwards Lifesciences to Host Earnings Conference Call on October 27, 2022 150

6.12 Oct 13, 2022: Merit Medical Systems to Announce Third Quarter Results on October 26, 2022 150

6.13 Sep 15, 2022: Zylox-Tonbridge Medical Technology Co Ltd announced interim report for 2022 150

6.14 Sep 07, 2022: Medtronic to appear at September investor conferences 150

6.15 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 150

6.16 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 153

6.17 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule 156

6.18 Aug 11, 2022: Neovasc Announces Second Quarter Financial Results and Provides Corporate Update 156

6.19 Aug 10, 2022: Olympus announces First Quarter Results 157

6.20 Aug 09, 2022: Olympus Corp. Announces Consolidated Financial Results for the Three Months of the Fiscal Year Ending March 31, 2023 158

6.21 Jul 27, 2022: Merit Medical Reports Results for Quarter Ended June 30, 2022 160

6.22 Jul 21, 2022: Edwards Lifesciences to Host Earnings Conference Call on July 28, 2022 161

6.23 Jul 20, 2022: Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance 161

6.24 Jul 14, 2022: Merit Medical Systems to Announce Second Quarter Results on July 27, 2022 162

6.25 Jul 08, 2022: Cordis Names Bryan Loo President of Asia-pacific Region 162

6.26 Jun 28, 2022: Nipro Notice of Resolutions at the 69th Annual General Meeting of Shareholders 163

6.27 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 163

6.28 May 31, 2022: CONMED Announces Private Offering of $600 Million of Convertible Senior Notes 164

6.29 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 165

6.30 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 166

6.31 May 23, 2022: Edwards Lifesciences to Present at the Bernstein 38th Annual Strategic Decisions Conference 166

6.32 May 12, 2022: Neovasc Announces First Quarter Financial Results and Provides Corporate Update 166

6.33 May 04, 2022: Conmed Announces First Quarter 2022 Financial Results 167

6.34 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022 169

6.35 Apr 27, 2022: Merit Medical Reports Results for Quarter Ended March 31, 2022 169

6.36 Apr 27, 2022: Boston Scientific Announces Results for First Quarter 2022 171

6.37 Apr 21, 2022: Merit Medical Announces Chief Operating Officer Transition 173

6.38 Apr 19, 2022: Edwards Lifesciences to Host Earnings Conference Call on April 26, 2022 173

6.39 Apr 14, 2022: Leading Quantum Scientist Prineha Narang Appointed to Named Professorship at UCLA 174

6.40 Apr 12, 2022: Zylox-Tonbridge Medical Technology Co Ltd announced annual report 2021 175

6.41 Apr 08, 2022: Olympus completes spin-out of Scientific Solutions business 175

6.42 Mar 10, 2022: Neovasc Announces Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update 175

6.43 Feb 04, 2022: Olympus Announces Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2022 176

6.44 Feb 02, 2022: Olympus Notification for the Candidate for the Board of Directors 177

7 Appendix 178

7.1 Methodology 178

7.2 About GlobalData 181

7.3 Contact Us 181

7.4 Disclaimer 181

Table

Peripheral Vascular Stents – Pipeline Products by Stage of Development 15

Peripheral Vascular Stents – Pipeline Products by Segment 16

Peripheral Vascular Stents – Pipeline Products by Territory 17

Peripheral Vascular Stents – Pipeline Products by Regulatory Path 18

Peripheral Vascular Stents – Pipeline Products by Estimated Approval Date 19

Peripheral Vascular Stents – Ongoing Clinical Trials 20

Peripheral Vascular Stents Companies – Pipeline Products by Stage of Development 21

Peripheral Vascular Stents – Pipeline Products by Stage of Development 24

3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview 27

Bioresorbable Drug Eluting Peripheral Polymer Stent – Product Status 27

Bioresorbable Drug Eluting Peripheral Polymer Stent – Product Description 27

Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 28

ESPRIT Bioresorbable Vascular Scaffold – Product Status 28

ESPRIT Bioresorbable Vascular Scaffold – Product Description 28

ESPRIT BTK Bioresorbable Vascular Scaffold – Product Status 29

ESPRIT BTK Bioresorbable Vascular Scaffold – Product Description 29

Abbott Vascular Inc – Ongoing Clinical Trials Overview 30

ESPRIT BTK Bioresorbable Vascular Scaffold – LIFE-BTK (Pivotal Investigation of Safety and Efficacy of BRS Treatment-below the Knee) Randomized Controlled Trial 31

ESPRIT BTK Bioresorbable Vascular Scaffold – LIFE-BTK Pharmacokinetics (PK) Sub-study 31

Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

Peripheral Spot Stent – Product Status 32

Peripheral Spot Stent – Product Description 32

Spot Stent System – Product Status 33

Spot Stent System – Product Description 33

Acotec Scientific Holdings Ltd – Ongoing Clinical Trials Overview 34

Spot Stent System – A Prospective, Multicenter and Randomized Controlled Trial to Evaluate the Efficacy and Safety of a Spot Stent System Using in the Percutaneous Transluminal Angioplasty of Femoropopliteal Arteries 35

amg International GmbH Pipeline Products & Ongoing Clinical Trials Overview 36

UNITY-B Peripheral Stent – Product Status 36

UNITY-B Peripheral Stent – Product Description 36

AndraTec GmbH Pipeline Products & Ongoing Clinical Trials Overview 37

Pillar Bifurcation Reconstruction Device – Product Status 37

Pillar Bifurcation Reconstruction Device – Product Description 37

Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

Bioresorbable Stent – Peripheral Vascular Disease – Product Status 38

Bioresorbable Stent – Peripheral Vascular Disease – Product Description 38

Biotyx Medical (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

IBS Titan – Product Status 39

IBS Titan – Product Description 39

Biotyx Medical (Shenzhen) Co Ltd – Ongoing Clinical Trials Overview 40

IBS Titan – A Prospective, Multi-Center, Randomized Trial Comparing the IBS Titan Sirolimus-Eluting Iron Bioresorbable Peripheral Scaffold System vs. Standard Balloon Angioplasty for Treatment of Below-the-Knee Arteries: GENIUS TRIAL 41

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 42

SAVAL Drug Eluting Stent BTK – Product Status 42

SAVAL Drug Eluting Stent BTK – Product Description 42

Symbiot Covered Stent System – Product Status 43

Symbiot Covered Stent System – Product Description 43

Wallstent RP Endoprosthesis – Venous Outflow Obstruction – Product Status 43

Wallstent RP Endoprosthesis – Venous Outflow Obstruction – Product Description 44

Boston Scientific Corp – Ongoing Clinical Trials Overview 45

Wallstent RP Endoprosthesis – Venous Outflow Obstruction – Sinai Vein Stent Registry 46

SAVAL Drug Eluting Stent BTK – A Randomized Trial Comparing the Drug-eluting Stent (DES) Below-the-knee (BTK) Vascular Stent System (DES BTK Vascular Stent System) Versus Percutaneous Transluminal Angioplasty (PTA) Treating Infrapopliteal Lesions in Subjects with Critical Limb Ischemia 47

Cardinal Health Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Palmaz-Mullins XD – Product Status 48

Palmaz-Mullins XD – Product Description 48

Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 49

Drug-Eluting Stent – Below The Knee – Product Status 49

Drug-Eluting Stent – Below The Knee – Product Description 49

Zenith Connection Endovascular Covered Stent – Product Status 50

Zenith Connection Endovascular Covered Stent – Product Description 50

Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 51

FlexStent Self Expanding Below-The-Knee Venous Stent System – Product Status 51

FlexStent Self Expanding Below-The-Knee Venous Stent System – Product Description 51

FlexStent Self Expanding Venous Stent System – Product Status 52

FlexStent Self Expanding Venous Stent System – Product Description 52

S.M.A.R.T. RADIANZ Vascular Stent System – Product Status 52

S.M.A.R.T. RADIANZ Vascular Stent System – Product Description 53

Tibial SE FlexStent – Product Status 53

Tibial SE FlexStent – Product Description 53

Cordis Corp – Ongoing Clinical Trials Overview 54

S.M.A.R.T. RADIANZ Vascular Stent System – Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access 55

CorInnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56

Hybrid Dynamic Stent – Product Status 56

Hybrid Dynamic Stent – Product Description 56

Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57

LifeJacket Stent Graft – Peripheral – Product Status 57

LifeJacket Stent Graft – Peripheral – Product Description 57

Efemoral Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 58

Efemoral Device – Product Status 58

Efemoral Device – Product Description 58

Efferent Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 59

RTI-LICD Plexisense – Product Status 59

RTI-LICD Plexisense – Product Description 59

Electroformed Stents Inc Pipeline Products & Ongoing Clinical Trials Overview 60

Helical Stent – Product Status 60

Helical Stent – Product Description 60

Patch Stent – Product Status 61

Patch Stent – Product Description 61

Pleated Stent – Product Status 61

Pleated Stent – Product Description 62

Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 63

PRAVA Bioresorbable Scaffold – Product Status 63

PRAVA Bioresorbable Scaffold – Product Description 63

Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 64

Peripheral Vascular Stent – Product Status 64

Peripheral Vascular Stent – Product Description 64

FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 65

GTU X-Stent – Product Status 65

GTU X-Stent – Product Description 65

GTU X2-Stent – Product Status 66

GTU X2-Stent – Product Description 66

HeMo Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 67

Peripheral Drug Eluting Stent – Product Status 67

Peripheral Drug Eluting Stent – Product Description 67

ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview 68

ID Venous System – Product Status 68

ID Venous System – Product Description 68

InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 69

PVGuard Peripheral – Product Status 69

PVGuard Peripheral – Product Description 69

Intressa Vascular SA Pipeline Products & Ongoing Clinical Trials Overview 70

Cardiatis FluidSmart 3D Stent – Product Status 70

Cardiatis FluidSmart 3D Stent – Product Description 70

Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 71

REMEDY – Drug Eluting – Product Status 71

REMEDY – Drug Eluting – Product Description 71

REMEDY – New Version – Product Status 72

REMEDY – New Version – Product Description 72

LeoMed, LLC Pipeline Products & Ongoing Clinical Trials Overview 73

Peripheral Arterial Stent – Product Status 73

Peripheral Arterial Stent – Product Description 73

Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 74

Bare Stent – Product Status 74

Bare Stent – Product Description 74

LimFlow SA Pipeline Products & Ongoing Clinical Trials Overview 75

LimFlow Percutaneous Deep Vein Arterialisation System – Product Status 75

LimFlow Percutaneous Deep Vein Arterialisation System – Product Description 75

LimFlow SA – Ongoing Clinical Trials Overview 76

LimFlow Percutaneous Deep Vein Arterialisation System – Percutaneous Deep Vein Arterialization for the Treatment of Late-stage Chronic Limb-threatening Ischemia: The PROMISE II Trial 77

LimFlow Percutaneous Deep Vein Arterialisation System – Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial 77

LimFlow Percutaneous Deep Vein Arterialisation System – Percutaneous Deep Vein Arterialization Post-market Study 77

LimFlow Percutaneous Deep Vein Arterialisation System – Percutaneous Deep Vein Arterialization Post-market Study 78

Lyra Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 79

Stanza Bioresorbable Pediatric Scaffold – Product Status 79

Stanza Bioresorbable Pediatric Scaffold – Product Description 79

Stanza Bioresorbable Self-Expanding Scaffold – Product Status 80

Stanza Bioresorbable Self-Expanding Scaffold – Product Description 80

Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 81

Credence BRS – Product Status 81

Credence BRS – Product Description 81

Interlace BRS – Product Status 82

Interlace BRS – Product Description 82

Melange BRS – Product Status 82

Melange BRS – Product Description 83

Meril Life Sciences Pvt Ltd – Ongoing Clinical Trials Overview 84

Credence BRS – To evaluate safety and performance of CREDENCE BRS Sirolimus Eluting BioResorbable Peripheral Scaffold System in subjects with de novo native peripheral artery lesions 85

Melange BRS – A Prospective, Multicentre, Open Label Clinical Study to Evaluate Safety and Performance of Melange BRS Sirolimus Eluting Bioresorbable Peripheral Scaffold System for Use as an Adjunct to Percutaneous Transluminal Renal Angioplasty of Atherosclerotic De Novo or Restenotic Lesion of the Renal Artery 86

Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 87

Peripheral Drug-Eluting Stent – Product Status 87

Peripheral Drug-Eluting Stent – Product Description 87

Micro Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 88

MicroStent – Product Status 88

MicroStent – Product Description 88

Micro Medical Solutions Inc – Ongoing Clinical Trials Overview 89

MicroStent – A Clinical Evaluation of the MicroStent Peripheral Vascular Stent in Subjects with Arterial Disease below the Knee: STAND 90

MicroStent – An All-comers Observational Study of the MicroStent Peripheral Vascular Stent System in Subjects with Peripheral Arterial Disease 90

Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 91

Marina – Product Status 91

Marina – Product Description 91

Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 92

Peripheral Stent – Product Status 92

Peripheral Stent – Product Description 92

NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 93

Micropatterned TFN Stent – Product Status 93

Micropatterned TFN Stent – Product Description 93

OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 94

Self-Expandable PTA Stent – Product Status 94

Self-Expandable PTA Stent – Product Description 94

Small Vessel – BTA – Product Status 95

Small Vessel – BTA – Product Description 95

PeriTec Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 96

Periteneum-Lined Balloon-Expandable Stent – Product Status 96

Periteneum-Lined Balloon-Expandable Stent – Product Description 96

Peritoneum Lined Self-Expanding Stent – Product Status 97

Peritoneum Lined Self-Expanding Stent – Product Description 97

QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 98

SOZO With 0.014″ PERSEUS-q PTA Balloon Catheter – Product Status 98

SOZO With 0.014″ PERSEUS-q PTA Balloon Catheter – Product Description 98

Tracheobronchial Stent – Product Status 99

Tracheobronchial Stent – Product Description 99

Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview 100

Qstent Peripheral Stent – Product Status 100

Qstent Peripheral Stent – Product Description 100

Reflow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 101

Temporary Spur Stent System – Product Status 101

Temporary Spur Stent System – Product Description 101

Reflow Medical, Inc. – Ongoing Clinical Trials Overview 102

Temporary Spur Stent System – A Non-randomized Pilot Study of the Temporary Spur Stent System for the Treatment of Lesions Located in the Infrapopliteal Arteries Using a LIMUS-base Drug-coated Balloon (DEEPER LIMUS) 103

Temporary Spur Stent System – A Non-randomized Trial of the Temporary Spur Stent System for the Treatment of Lesions Located in the Infrapopliteal Arteries Outside of the United States 103

Temporary Spur Stent System – A Prospective Single-Arm Multicenter Study of the Bare Temporary Spur Stent System for the Treatment of Vascular Lesions Located in the Infrapopliteal Arteries Below the Knee (DEEPER REVEAL) 103

Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 104

Bio-Leap Below-The-Knee (BTK) BRS System – Product Status 104

Bio-Leap Below-The-Knee (BTK) BRS System – Product Description 104

Shanghai Changde Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 105

Cardiac Stent – Arteriovenous Fistula – Product Status 105

Cardiac Stent – Arteriovenous Fistula – Product Description 105

Cardiac Stent – Deep Vein Thrombosis – Product Status 106

Cardiac Stent – Deep Vein Thrombosis – Product Description 106

Cardiac Stent – Peripheral Arterial Stenosis – Product Status 106

Cardiac Stent – Peripheral Arterial Stenosis – Product Description 106

Cardiac Stent – Varicose Veins – Product Status 107

Cardiac Stent – Varicose Veins – Product Description 107

Shanghai MicroPort Endovascular MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 108

Venous Stent – Product Status 108

Venous Stent – Product Description 108

Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 109

GSTREAM Rapamycin Drug-Eluting Peripheral Vascular Stent – Product Status 109

GSTREAM Rapamycin Drug-Eluting Peripheral Vascular Stent – Product Description 109

Iliac Vein Stent – Product Status 110

Iliac Vein Stent – Product Description 110

Lower Limb Arterial Drug-Loaded Stent – Product Status 110

Lower Limb Arterial Drug-Loaded Stent – Product Description 111

Peripheral Vascular Stent – Product Status 111

Peripheral Vascular Stent – Product Description 111

Suzhou Yinluo Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 112

Iliac Vein Stent – Product Status 112

Iliac Vein Stent – Product Description 112

Synergy Flow Ltd Pipeline Products & Ongoing Clinical Trials Overview 113

ArtiStent – Product Status 113

ArtiStent – Product Description 113

Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 114

TephaFLEX Fully Absorbable Peripheral Stent – Product Status 114

TephaFLEX Fully Absorbable Peripheral Stent – Product Description 114

TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview 115

Archer Stent – Product Status 115

Archer Stent – Product Description 115

Tractivus SL Pipeline Products & Ongoing Clinical Trials Overview 116

Bacteriaphobic Tracheal Stent – Product Status 116

Bacteriaphobic Tracheal Stent – Product Description 116

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 117

Tracheal Stent – Product Status 117

Tracheal Stent – Product Description 117

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 118

Dual Chamber Stent – Product Status 118

Dual Chamber Stent – Product Description 118

University of Pittsburgh Medical Center Pipeline Products & Ongoing Clinical Trials Overview 119

Retrievable Vascular Stent – Product Status 119

Retrievable Vascular Stent – Product Description 119

Vascular Bioresorbable Technologies Pipeline Products & Ongoing Clinical Trials Overview 120

Drug Eluting Scaffold – Peripheral Artery Disease – Product Status 120

Drug Eluting Scaffold – Peripheral Artery Disease – Product Description 120

Drug Free Pure Bioresorbable Scaffold – Peripheral Artery Disease – Product Status 121

Drug Free Pure Bioresorbable Scaffold – Peripheral Artery Disease – Product Description 121

Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview 122

Covered Peripheral Stent – Product Status 122

Covered Peripheral Stent – Product Description 122

Prograft SX – Product Status 123

Prograft SX – Product Description 123

Vesper Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 124

Vesper Duo Venous Stent System – Product Status 124

Vesper Duo Venous Stent System – Product Description 124

Vesper Medical Inc – Ongoing Clinical Trials Overview 125

Vesper Duo Venous Stent System – Prospective, Single-centre Post-Market Clinical Follow-up (PMCF) Study to Evaluate Safety and Performance of the DUO Venous Stent 126

Vesper Duo Venous Stent System – Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System 126

Vinnova Pipeline Products & Ongoing Clinical Trials Overview 127

Grency Venous Stent System – Product Status 127

Grency Venous Stent System – Product Description 127

VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 128

MR-Enhancing Balloon Expandable Stent – Product Status 128

MR-Enhancing Balloon Expandable Stent – Product Description 128

MR-Enhancing Self-Expanding Stent – Product Status 129

MR-Enhancing Self-Expanding Stent – Product Description 129

Wake Forest University Health Sciences Pipeline Products & Ongoing Clinical Trials Overview 130

Vascular Stent – Product Status 130

Vascular Stent – Product Description 130

Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview 131

Ideal BioStent – Peripheral – Product Status 131

Ideal BioStent – Peripheral – Product Description 131

Unison Peripheral Stent System – Product Status 132

Unison Peripheral Stent System – Product Description 132

Zorion Medical Pipeline Products & Ongoing Clinical Trials Overview 133

ZMED Absorbable Drug Eluting Stent – Product Status 133

ZMED Absorbable Drug Eluting Stent – Product Description 133

Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 134

Multi-Spot Stent System – Product Status 134

Multi-Spot Stent System – Product Description 134

ZENFLEX Pinto Spot Stent System – Product Status 135

ZENFLEX Pinto Spot Stent System – Product Description 135

ZENFLEX Pro Peripheral Drug Eluting Stent System – Product Status 135

ZENFLEX Pro Peripheral Drug Eluting Stent System – Product Description 136

Zylox-Tonbridge Medical Technology Co Ltd – Ongoing Clinical Trials Overview 137

ZENFLEX Pro Peripheral Drug Eluting Stent System – Swedish Drug-elution Trial in Peripheral Arterial Disease – A Multicenter, Prospective Randomized Controlled Clinical Trial Based on the Swedish Vascular Registry (SWEDVASC) Platform 138

ZENFLEX Pro Peripheral Drug Eluting Stent System – The Safety and Efficacy of Drug Eluting Peripheral Vascular Stent System for the Treatment of Superficial Femoral Artery Stenosis and /or Occlusion: A Multi-center Stratified Randomized Single-blind Controlled Trial 138

ZENFLEX Pinto Spot Stent System – A Prospective, Multicenter, Randomized Controlled Trail Using Spot Stenting to Treat Lower Extremity Post-angioplasty Dissection 139

Glossary 180

Figures

Peripheral Vascular Stents – Pipeline Products by Stage of Development 15

Peripheral Vascular Stents – Pipeline Products by Segment 16

Peripheral Vascular Stents – Pipeline Products by Territory 17

Peripheral Vascular Stents – Pipeline Products by Regulatory Path 18

Peripheral Vascular Stents – Pipeline Products by Estimated Approval Date 19

Peripheral Vascular Stents – Ongoing Clinical Trials 20

Frequently asked questions

Peripheral Vascular Stents Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Peripheral Vascular Stents Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Peripheral Vascular Stents Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Peripheral Vascular Stents Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.